Table 1: Characteristics of the study groups.
| Clinical data | Overall (n = 39) | CTL (n = 12) | HT (n = 14) | STR (n = 13) | P-value† |
Sex, n (%) Female Male |
17 (43.6) 22 (56.4) |
7 (58.3) 5 (41.7) |
5 (35.7) 9 (64.3) |
5 (38.5) 8 (61.5) |
0.46 |
Age (in years) Mean ± SD Median (P25-P75) |
60.4 ± 11.5 62 (54-73) |
59.3 ± 8.6 60.5 (54-65.5) |
59.1 ± 10.7 60 (53-70) |
62.8 ± 14.7 63 (54-73) |
0.67 |
BMI (kg/m2) Mean ± SD Median (P25-P75) |
30.7 ± 5.8 28.3 (26.6-35.1) |
28.7 ± 5.4 26.8 (24.7-33.3) |
31.8 ± 7.0 28.8 (27.2-35.1) |
31.2 ± 4.8 31.9 (27.4-36.3) |
0.39 |
Pulse Rate (beats/min) Mean ± SD Median (P25-P75) |
74.4 ± 14.6 76 (63-82) |
73.9 ± 10.8 72.5 (64-82.5) |
70.4 ± 15.2 65 (58-81) |
79.3 ± 16.5 78 (69-82) |
0.29 |
Pulse Pressure (mmHg) Mean ± SD Median (P25-P75) |
56.9 ± 15.6 57 (45-65) |
57.0 ± 10.7 57.5 (51-62) |
53.4 ± 13.5 50.5 (43-65) |
60.5 ± 20.9 60 (45-72) |
0.51 |
SBP (mmHg) Mean ± SD Median (P25-P75) |
133.9 ± 20.3 129 (122-142) |
126.5 ± 10.9 125.5 (122.5-133.5) |
128.9 ± 15.5 129.5 (114-135) |
146.2 ± 26.3 149 (122-164) |
0.26‡ |
DBP (mmHg) Mean ± SD Median (P25-P75) |
77.1 ± 13.7 78 (65-84) |
69.5 ± 11.0 69.5 (62.5-80) |
75.5 ± 11.7 75.5 (64-82) |
85.7 ± 14.0 83 (78-89) |
< 0.01* |
CTL: Control Patients; HT: Hypertensive Patients Receiving Treatment; STR: Ischemic Stroke Patients; BMI: Body Mass Index; SBP: Systolic Blood Pressure; DBP: Diastolic Blood Pressure.
†Chi-squared and One-way ANOVA tests were performed, when appropriate, to calculate p-values unless otherwise specified; ‡Fisher's exact or Kruskal-Wallis test was performed, as appropriate, to calculate p-values; *Statistically significant (p < 0.05).